William Geist - 01 Feb 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
PRESIDENT, PROTEIN SCIENCES
Signature
/s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
01 Feb 2024
Net transactions value
-$76,148
Form type
4
Filing time
05 Feb 2024, 18:36:03 UTC
Previous filing
09 Nov 2023
Next filing
19 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Tax liability $76,148 -1,111 -13% $68.54 7,759 01 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TECH Restricted Stock Units 3,360 01 Feb 2024 Common Stock 3,360 Direct F2, F3
holding TECH Stock Options (Right to Buy) 11,936 01 Feb 2024 Common Stock 11,936 $100.39 Direct F3
holding TECH Stock Options (Right to Buy) 15,912 01 Feb 2024 Common Stock 15,912 $100.39 Direct F4
holding TECH Restricted Stock Units 7,140 01 Feb 2024 Common Stock 7,140 Direct F2, F5
holding TECH Stock Options (Right to Buy) 22,200 01 Feb 2024 Common Stock 22,200 $94.52 Direct F5
holding TECH Stock Options (Right to Buy) 29,600 01 Feb 2024 Common Stock 29,600 $94.52 Direct F6
holding TECH Restricted Stock Units 9,074 01 Feb 2024 Common Stock 9,074 Direct F2, F7
holding TECH Stock Options (Right to Buy) 24,424 01 Feb 2024 Common Stock 24,424 $84.61 Direct F7
holding TECH Stock Options (Right to Buy) 30,059 01 Feb 2024 Common Stock 30,059 $84.61 Direct F8
holding TECH Restricted Stock Units 19,823 01 Feb 2024 Common Stock 19,823 Direct F2, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,320 shares of restricted stock units for which the risk of forfeiture will lapse on 2/1/2025.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F4 Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 3,976 shares vest on each of 2/1/2025 and 2/1/2026.
F5 Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
F7 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
F9 9,912 restricted stock units vest on 11/1/2024 and 9,911 restricted stock units vest on 11/1/2025.